000 | 01363 a2200325 4500 | ||
---|---|---|---|
005 | 20250514054208.0 | ||
264 | 0 | _c20030731 | |
008 | 200307s 0 0 eng d | ||
022 | _a1570-0232 | ||
024 | 7 |
_a10.1016/s1570-0232(02)00816-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPommier, F | |
245 | 0 | 0 |
_aQuantitative determination of rivastigmine and its major metabolite in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. _h[electronic resource] |
260 |
_bJournal of chromatography. B, Analytical technologies in the biomedical and life sciences _cFeb 2003 |
||
300 |
_a301-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aCalibration |
650 | 0 | 4 |
_aCarbamates _xblood |
650 | 0 | 4 |
_aCholinesterase Inhibitors _xblood |
650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPhenylcarbamates |
650 | 0 | 4 | _aReference Standards |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aRivastigmine |
650 | 0 | 4 | _aSensitivity and Specificity |
700 | 1 | _aFrigola, R | |
773 | 0 |
_tJournal of chromatography. B, Analytical technologies in the biomedical and life sciences _gvol. 784 _gno. 2 _gp. 301-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1570-0232(02)00816-4 _zAvailable from publisher's website |
999 |
_c12309110 _d12309110 |